MetLife Statistics
Total Valuation
MetLife has a market cap or net worth of $51.04 billion. The enterprise value is $94.42 billion.
Important Dates
The next confirmed earnings date is Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | Feb 3, 2026 |
Share Statistics
MetLife has 652.05 million shares outstanding. The number of shares has decreased by -5.32% in one year.
| Current Share Class | 652.05M |
| Shares Outstanding | 652.05M |
| Shares Change (YoY) | -5.32% |
| Shares Change (QoQ) | -1.03% |
| Owned by Insiders (%) | 0.23% |
| Owned by Institutions (%) | 76.40% |
| Float | 544.55M |
Valuation Ratios
The trailing PE ratio is 16.49 and the forward PE ratio is 7.93. MetLife's PEG ratio is 0.74.
| PE Ratio | 16.49 |
| Forward PE | 7.93 |
| PS Ratio | 0.66 |
| Forward PS | 0.63 |
| PB Ratio | 1.79 |
| P/TBV Ratio | 2.82 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 2.99 |
| PEG Ratio | 0.74 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 29.76 |
| EV / Sales | 1.23 |
| EV / EBITDA | 15.84 |
| EV / EBIT | 18.13 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.90, with a Debt / Equity ratio of 2.26.
| Current Ratio | 1.90 |
| Quick Ratio | 1.60 |
| Debt / Equity | 2.26 |
| Debt / EBITDA | 10.96 |
| Debt / FCF | n/a |
| Interest Coverage | 4.91 |
Financial Efficiency
Return on equity (ROE) is 12.02% and return on invested capital (ROIC) is 4.44%.
| Return on Equity (ROE) | 12.02% |
| Return on Assets (ROA) | 0.46% |
| Return on Invested Capital (ROIC) | 4.44% |
| Return on Capital Employed (ROCE) | 0.75% |
| Weighted Average Cost of Capital (WACC) | 4.30% |
| Revenue Per Employee | $1.68M |
| Profits Per Employee | $68,978 |
| Employee Count | 46,000 |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MetLife has paid $1.26 billion in taxes.
| Income Tax | 1.26B |
| Effective Tax Rate | 26.99% |
Stock Price Statistics
The stock price has increased by +4.15% in the last 52 weeks. The beta is 0.73, so MetLife's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | +4.15% |
| 50-Day Moving Average | 73.28 |
| 200-Day Moving Average | 77.33 |
| Relative Strength Index (RSI) | 65.73 |
| Average Volume (20 Days) | 3,257,725 |
Short Selling Information
The latest short interest is 12.54 million, so 1.92% of the outstanding shares have been sold short.
| Short Interest | 12.54M |
| Short Previous Month | 12.85M |
| Short % of Shares Out | 1.92% |
| Short % of Float | 2.30% |
| Short Ratio (days to cover) | 3.46 |
Income Statement
In the last 12 months, MetLife had revenue of $77.08 billion and earned $3.17 billion in profits. Earnings per share was $4.71.
| Revenue | 77.08B |
| Gross Profit | 18.01B |
| Operating Income | 5.21B |
| Pretax Income | 4.66B |
| Net Income | 3.17B |
| EBITDA | 5.96B |
| EBIT | 5.21B |
| Earnings Per Share (EPS) | $4.71 |
Full Income StatementBalance Sheet
The company has $25.63 billion in cash and $65.35 billion in debt, giving a net cash position of -$43.32 billion or -$66.44 per share.
| Cash & Cash Equivalents | 25.63B |
| Total Debt | 65.35B |
| Net Cash | -43.32B |
| Net Cash Per Share | -$66.44 |
| Equity (Book Value) | 28.92B |
| Book Value Per Share | 43.33 |
| Working Capital | 43.03B |
Full Balance SheetCash Flow
| Operating Cash Flow | 17.09B |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | -591.00M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 23.36%, with operating and profit margins of 6.76% and 4.38%.
| Gross Margin | 23.36% |
| Operating Margin | 6.76% |
| Pretax Margin | 6.05% |
| Profit Margin | 4.38% |
| EBITDA Margin | 7.73% |
| EBIT Margin | 6.76% |
| FCF Margin | n/a |